Table 2:

Association of vascular risk factors and the presence of microinfarcts in the deep gray matter on 7T MR imaginga

Patients with Microinfarcts in the Deep Gray Matter (n = 28)Patients without Microinfarcts in the Deep Gray Matter (n = 185)All Patients (n = 213)Microinfarct (Presence vs Absence) RR (95% CI)b
Age (yr)70 (SD, 7)64 (SD, 9)64 (SD, 9)1.05 (1.02–1.08)c,d
Sex (% men)85.782.282.60.78 (0.30–2.02)e
History of stroke (%)50.023.226.82.88 (1.24–6.67)d
BMI (kg/m2)28 (SD, 4)27 (SD, 4)27 (SD, 4)1.20 (0.87–1.65)
Smoking (pack-years)f27 (0, 56)20 (0, 47)22 (0, 49)1.11 (0.87–1.42)
Alcohol intake
    No or <1 U/week (%)22.226.525.91 (reference)
    1–10 U/week (%)59.341.143.41.55 (0.67–3.61)
    ≥11 U/week (%)18.532.430.70.65 (0.22–1.98)
Hypertension (%)96.472.475.63.16 (1.30–7.65)d
Diabetes mellitus (%)14.316.216.00.85 (0.32–2.21)
Carotid stenosis ≥50% (%)17.97.68.91.39 (0.70–2.75)
Hypercholesterolemia (%)77.886.485.31.33 (0.86–2.05)
IMT (mm)1.0 (SD, 0.3)0.8 (SD, 0.2)0.9 (SD, 0.2)1.29 (1.04–1.61)d
ABI1.1 (SD, 0.2)1.1 (SD, 0.1)1.1 (SD, 0.2)0.86 (0.67–1.11)
Homocysteine (µmol/l)13.0 (SD, 5.2)12.5 (SD, 4.3)12.5 (SD, 4.4)1.07 (0.40–2.82)
APOB (g/L)0.8 (SD, 0.2)0.8 (SD, 0.2)0.8 (SD, 0.2)0.84 (0.58–1.23)
Metabolic syndrome60.751.452.61.47 (0.74–2.91)
≥1 APOE ε4 allele (%)35.728.129.11.58 (0.79–3.20)
  • Note:—BMI indicates body mass index; IMT, intima-media thickness; ABI, ankle brachial index; APOB, apolipoprotein B; APOE, apolipoprotein E

  • a Characteristics are presented as mean (SD) or percentage. RR represents the relative risk for microinfarcts in the presence of a risk factor (in case of a dichotomous variable) or for 1 SD increase in the risk factor (in case of a continuous variable).

  • b Log-binomial regression with adjustment for age.

  • c Per year increase.

  • d P < .05.

  • e Men versus women.

  • f Median (10th percentile, 90th percentile). Natural log-transformed due to a non-normal distribution in the analysis.